Not applicableStudy completedNCT06310343What this trial is testingADAs to AlemtuzumabWho this might be right forMultiple Sclerosis Queen Mary University of London 15
Early research (Phase 1)Not Yet RecruitingNCT07429474What this trial is testingSafety and Immunogenicity of PRO-169 in Patients With Diabetic Macular EdemaWho this might be right forImmunogenicityAnti-drug Antibodies (ADAs) Laboratorios Sophia S.A de C.V. 60